Curcumin plus black-pepper extract shifts blood fats — except LDL

Dyslipidaemia — an unhealthy pattern of blood fats — is a known risk factor for cardiovascular disease, and interest in food-derived compounds that might improve it keeps growing. Curcuminoids, the active constituents of turmeric, are frequently paired with piperine from black pepper, and research suggests the combination can alter serum lipids. Individual trials, however, have produced inconsistent findings, leaving the overall effect unclear. This meta-analysis set out to pool the randomised evidence and establish what curcuminoids plus piperine actually do to the standard lipid panel in adults.

The authors systematically searched databases up to August 2025 for randomised controlled trials of curcuminoids plus piperine co-supplementation in adults. Sixteen RCTs qualified, encompassing 1038 participants — 522 in intervention groups and 516 in controls. For each lipid outcome, they calculated weighted mean differences with 95% confidence intervals and pooled them using a random-effects model to account for variability between studies. The panel assessed comprised triglycerides, total cholesterol, HDL cholesterol and LDL cholesterol.

The combination significantly reduced triglycerides, with a weighted mean difference of -18.64 mg/mL, and total cholesterol, at -6.58 mg/mL. HDL cholesterol — the fraction where higher is generally regarded as favourable — rose by 1.51 mg/mL. LDL cholesterol, however, did not fall significantly: the pooled difference of -2.20 mg/mL had a confidence interval spanning -7.22 to 2.80. The authors report that benefits were most pronounced with more prolonged supplementation and in individuals with dyslipidaemia, metabolic disorders and overweight.

This pooling helps resolve the inconsistency across individual curcumin trials by showing which lipid fractions respond and which do not. The pattern — triglycerides and total cholesterol down, HDL modestly up, LDL essentially unmoved — matters because LDL is a central target in cardiovascular prevention, so the combination looks like a complement rather than a substitute for established lipid-lowering approaches. The authors frame it as a possible complementary therapy for dyslipidaemia management, and open questions remain about optimal dose, duration and which populations benefit most.

If your blood tests show raised triglycerides or total cholesterol, this is a reason to think the curcuminoid-piperine combination has genuine, if modest, lipid effects in pooled trial data — particularly for people with dyslipidaemia, metabolic issues or excess weight, and with longer supplementation. It is equally a reason to note what it did not do: LDL cholesterol, the fraction most treatment approaches centre on, showed no significant change. On this evidence the combination reads as a possible complement to, not a replacement for, established lipid management.